VOTING AGREEMENTVoting Agreement • June 29th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 20, 2005, by and among Clinical Data, Inc., a Delaware corporation (“Clinical Data”), Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Randal J. Kirk (“Kirk”), RJK, L.L.C., a Virginia limited liability company that is controlled by Kirk (“RJK”), New River Management II, LP, a Virginia limited partnership that is controlled by Kirk (“New River”), Kirkfield, L.L.C., a Virginia limited liability company that is controlled by Kirk (“Kirkfield”), Third Security Staff 2001 LLC, a Virginia limited liability company (“Staff LLC”), and Zhong Mei, L.L.C., a Virginia limited liability company (“Zhong Mei”, and collectively with Kirk, RJK, New River, and Staff LLC, the “Stockholders”, and each individually, a “Stockholder”).
VOTING AGREEMENTVoting Agreement • June 29th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 20, 2005, by and among Clinical Data, Inc., a Delaware corporation (“Clinical Data”), Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Israel M. Stein, M.D. (the “Stockholder”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • June 29th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 20, 2005, is by and among Clinical Data, Inc., a Delaware corporation (the “Parent”), Safari Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of the Parent (the “Transitory Subsidiary”), and Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
